Delivery Order SPE2DB20D3103-SPE2DB25FQ3X6
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/ml ampules under a firm fixed-price contract valued at $1,191.06. The award was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a non-competitive award issued under an existing contract vehicle, reflecting the agency's...
- The Defense Logistics Agency awarded a delivery order valued at $1,198.90 to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/mL ampules, with an ultimate completion date of August 29, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $1,122.00 to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/mL ampules. This non-competitive delivery order, issued on August 5, 2025, represents a firm fixed-price purchase under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. As a leading pharmaceutical distributor,...
- The Defense Logistics Agency (DLA) awarded a $1,013.53 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/ml ampules under a firm fixed price contract. The award was made on September 12, 2025, with an ultimate completion date of September 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was not set aside and was competitively awarded, demonstrating AmerisourceBergen's continued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Epinephrine 1 mg/mL ampules, valued at $1,311.41. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is scheduled for completion by August 21, 2025,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $39,721.62 to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/mL ampules. This firm fixed-price, non-set-aside contract was executed on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a critical pharmaceutical supply requirement for federal medical procurement, supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Epinephrine 1 MG/ML Ampuls with a ceiling value of $2,637.68 under a firm fixed price contract type. The delivery order was awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, and will be performed in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded contract that represents a child order under AmerisourceBergen's larger federal contract vehicle with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Epinephrine 1 mg/ml ampules with a ceiling value of $2,582.69. This is a firm fixed price delivery order with no set-aside designation, reflecting open competition for the award. The contract is scheduled for ultimate completion on September 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Epinephrine 1 mg/ml ampules. This non-set-aside, competitively awarded contract is valued at $1,699.56 with a firm fixed price and an ultimate completion date of July 22, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $3,366.00 to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/ml ampules. This firm fixed-price, competitively awarded contract was executed on September 18, 2025, with an ultimate completion date of September 19, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ3X6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,122.00 to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/mL in ampule format. This competitive award, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, utilizes firm fixed pricing with no set-aside designation. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, supporting federal medical procurement requirements for military and veteran healthcare systems. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, maintains an extensive portfolio of federal contract awards demonstrating its capability to meet competitive procurement requirements across multiple therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/18/25 |